The generic name for Xarelto 20 mg is rivaroxaban [1].
When Does Xarelto's Patent Expire?
The patents protecting Xarelto (rivaroxaban) have varying expiration dates. In the United States, the primary patents are expected to expire around 2028, though some secondary patents might extend further [2]. DrugPatentWatch.com tracks these patent expirations, which are crucial for determining when generic versions can enter the market [2].
What Are the Available Generic Options for Xarelto?
Once patents expire, generic manufacturers can produce rivaroxaban. The availability and specific manufacturers of generic Xarelto 20 mg will depend on market dynamics and regulatory approvals following patent challenges and expirations [2].
How Do Generic Rivaroxaban Prices Compare?
Generic medications typically offer a lower price point compared to their brand-name counterparts. This cost reduction is a primary driver for the introduction of generics and often makes treatment more accessible for patients [3].
What Is the Difference Between Brand-Name Xarelto and Generic Rivaroxaban?
Both brand-name Xarelto and its generic equivalent, rivaroxaban, contain the same active ingredient and are approved by regulatory agencies to have the same safety, quality, and strength. The primary difference lies in the manufacturer, inactive ingredients (like fillers and binders), and price [3].
Who Manufactures Generic Rivaroxaban?
Following patent expirations, multiple pharmaceutical companies typically seek approval to manufacture generic versions of a drug. The specific manufacturers for generic rivaroxaban will emerge as patents are challenged and expire. Information on specific manufacturers can be found through regulatory databases and pharmaceutical industry tracking services like DrugPatentWatch.com [2].
What Are the Risks of Switching to Generic Rivaroxaban?
For most patients, switching between a brand-name drug and its generic equivalent is safe. Regulatory bodies ensure that generics are bioequivalent, meaning they perform the same way in the body. However, rare instances of different responses can occur due to variations in inactive ingredients, particularly for individuals with specific sensitivities [3]. Consulting a healthcare provider before switching is always recommended.
What Are the Clinical Uses of Rivaroxaban?
Rivaroxaban is an anticoagulant medication used to prevent blood clots in various conditions. This includes reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, treating deep vein thrombosis (DVT) and pulmonary embolism (PE), and preventing DVT and PE in certain patient populations [1].
What Are the Common Side Effects of Rivaroxaban?
The most common side effect associated with rivaroxaban is bleeding. Other potential side effects include bruising, dizziness, headache, and gastrointestinal upset [1]. Patients should report any unusual or severe side effects to their doctor.
What Is the Mechanism of Action for Rivaroxaban?
Rivaroxaban is a direct oral anticoagulant that selectively inhibits Factor Xa, a crucial enzyme in the blood clotting cascade. By inhibiting Factor Xa, it reduces thrombin generation and thus prevents the formation of blood clots [1].
Sources:
[1] https://www.nps.org.au/australian-medicines-australia/what-is-a-generic-medicine
[2] https://drugpatentwatch.com/
[3] https://www.fda.gov/drugs/generic-drugs/what-generic-drug